Altman Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.54M | Buy |
36,420
+1,160
| +3% | +$81K | 1.04% | 30 |
|
|
2025
Q1 | $2.34M | Buy |
35,260
+19,309
| +121% | +$1.28M | 1.08% | 25 |
|
|
2024
Q4 | $1.37M | Buy |
15,951
+117
| +0.7% | +$10.1K | 0.59% | 79 |
|
|
2024
Q3 | $1.89M | Sell |
15,834
-33
| -0.2% | -$3.93K | 0.84% | 48 |
|
|
2024
Q2 | $2.26M | Sell |
15,867
-63
| -0.4% | -$8.99K | 1.29% | 22 |
|
|
2024
Q1 | $2.03M | Buy |
15,930
+461
| +3% | +$58.8K | 0.99% | 30 |
|
|
2023
Q4 | $1.6M | Buy |
15,469
+192
| +1% | +$19.9K | 0.84% | 45 |
|
|
2023
Q3 | $1.39M | Buy |
+15,277
| New | +$1.39M | 0.87% | 48 |
|